公司资料
ContraFect Corporation 股价、新闻与催化剂
- 股票代码:
- CFRX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
目前无法获取 CFRX 的收盘价变动背景。
公司概览
业务概览
ContraFect Corporation was a biotechnology company focused on anti-infective proteins and pathogen-targeting therapies before becoming a legacy ticker. Its story was centered on using biologic mechanisms to address difficult infectious diseases.
所在地与行业分类
ContraFect was headquartered in the United States and listed on NASDAQ. It sat in small-cap anti-infective biotechnology.
商业模式特征
The company depended on clinical validation, capital support, and the ability to advance a narrow infectious-disease pipeline. Investors historically watched data and financing runway.
生物医药行业定位
ContraFect belongs to the historical anti-infective biotech bucket. It was a catalyst-sensitive name where program progress and capital were always central.
未来催化剂
- ContraFect is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live anti-infective milestone. The market is focused on residual value.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。